CrushSCI.com
Journal Selection & Manuscript Polishing Services
ONCOLOGIST 临时占位封面 Medicine
Back to journal directory

Review Cycle Records

ONCOLOGIST

Oxford SCIE OA
2026 Emerging Zone 22025 CAS Zone 22025 JCR Q2
76Average days
59Median days
53Fastest days
154Longest days
5772025 publications

Paper Review Records

All Paper Review Records

5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.

59 days

Overall survival in oncology phase III trials: an individual patient level meta-analysis (OPTIMA)

AuthorsAlexander D Sherry; Noah Meimoun; Avital M Miller; Jessica Liu; Kimi Chauhan; Ramez Kouzy; Timothy A Lin; Pavlos Msaouel; Ethan B Ludmir

Affiliations1. Department of Radiation Oncology, Mayo Clinic , Rochester, MN 55905,; 2. Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,; 3. Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,; 4. Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,; 5. Department of Gastrointestinal Radiation Oncology, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,; 6. Department of Biostatistics, The University of Texas MD Anderson Cancer Center , Houston, TX 77030,

Source PDF DOI Publisher page
53 days

Symptom clusters and quality of life among patients with thyroid cancer during early survivorship: a national multicenter cross-sectional study

AuthorsJie Gao; Xin Wang; Jiayan Cao; Yanyan Chen; Yi Tu; Xiaohua Song; Yingchun Zhou; Duo Tao; Lianjie Zhang; Jing Zhao

Affiliations1. Tianjin Medical University Cancer Institute & Hospital, National Clinical Research Center for Cancer, Tianjin’s Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy , Tianjin 300060,; 2. The Third Clinical Medical College of Xinjiang Medical University , Urumqi, 830011,; 3. Xinjiang Uygur Autonomous Region , Urumqi, 830011,; 4. Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences , Hangzhou, Zhejiang 310022,; 5. Hunan Cancer Hospital/The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University , Changsha, Hunan 410000,; 6. Chongqing University Cancer Hospital, Chongqing Cancer Research Institute , Chongqing 400030,; 7. Sun Yat-sen Memorial Hospital, Sun Yat-sen University , Guangzhou, Guangdong 510120,; 8. The First Bethune Hospital of Jilin University , Changchun, Jilin 130031,

Source PDF DOI Publisher page
53 days

Preventive effect of goshajinkigan on paclitaxel-induced peripheral neuropathy: an open-label, randomized phase II study (OLCSG2101)

AuthorsTakaaki Tanaka; Go Makimoto; Naoki Nakamura; Yuka Kato; Isao Oze; Toshihide Yokoyama; Shoichi Kuyama; Satoru Senoo; Koji Inoue; Hirohisa Ichikawa; Yoshinobu Maeda; Yosuke Togashi; Katsuyuki Hotta

Affiliations1. Department of Hematology, Oncology and Respiratory Medicine, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , Okayama 700-8558,; 2. Department of Respiratory Medicine, Okayama University Hospital , Okayama 700-8558,; 3. Department of Thoracic Oncology and Medicine, National Hospital Organization Shikoku Cancer Center , Ehime 791-0280,; 4. Division of Cancer Information and Control, Aichi Cancer Center Research Institute , Nagoya 464-8681,; 5. Department of Respiratory Medicine, Kurashiki Central Hospital , Okayama 710-8602,; 6. Department of Respiratory Medicine, Iwakuni Clinical Center , Yamaguchi 740-8510,; 7. Department of Respiratory Medicine, NHO Fukuyama Medical Center , Hiroshima 720-8520,; 8. Department of Respiratory Medicine, Ehime Prefectural Central Hospital , Ehime 790-0024,; 9. Department of Respiratory Medicine, KKR Takamatsu Hospital , Kagawa 760-0018,; 10. Department of Tumor Microenvironment, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University , Okayama 700-8558,; 11. Advanced Research Field, Institute for Emerging Medical Innovation, Okayama University Hospital , Okayama 700-8558,; 12. Kindai University, Faculty of Medicine , Osaka 590-0197,; 13. Center for Innovative Clinical Medicine, Okayama University Hospital , Okayama 700-8558,

Source PDF DOI Publisher page
154 days

Global management of drug–drug interaction in patients with prostate cancer: international survey by Meet-URO group and ONCOassist

AuthorsAnna Amela Valsecchi; Michele Maffezzoli; Maria Concetta Cursano; Mattia Di Civita; Fiorenza Santamaria; Stefania Kingspergher; Elisa Zanardi; Giuseppe Procopio; Suleka Ashok; Lakshmi Ramachandran; Renita George; Kevin Bambury; Richard Bambury; Eoin O’Carroll; Giuseppe Luigi Banna; Massimo Di Maio; Daniele Santini

Affiliations1. Department of Oncology, University of Turin, A.O.U. Città della Salute e della Scienza di Torino, Ospedale Molinette, 10126,; 2. Oncology Unit, University Hospital of Parma, Parma, 43126,; 3. Department of Oncology, Ospedale Ca’ Foncello, Treviso, 31100,; 4. Department of Experimental Medicine, Sapienza University of Rome , Rome, 00161,; 5. Department of Medical Oncology, Medical Oncology Unit, Sandro Pertini Hospital , Rome, 00157,; 6. Ospedale San Maurizio , Bolzano, 39100,; 7. UO Clinica di Oncologia Medica, IRCCS Azienda Ospedaliera Metropolitana , Genoa, 16132,; 8. Department of Oncology, Genitourinary Medical Oncology, Fondazione IRCCS Istituto Nazionale Tumori Milano , Milan, 20133,; 9. ONCOassist , V93 T8K7,; 10. Portsmouth Hospitals University NHS Trust , Portsmouth, PO6 3LY,; 11. Faculty of Science and Health, School of Pharmacy and Biomedical Sciences, University of Portsmouth , Portsmouth, PO1 2UP,; 12. Department of Sciences and Medical-Surgery Biotechnologies, La Sapienza, Università di Roma , Rome, 04100,

Source PDF DOI Publisher page
61 days

The insufficient publication of early-phase clinical trials in oncology

AuthorsMerel J J Lucassen; Tim Schutte; Alwin D R Huitema; Neeltje Steeghs

Affiliations1. Department of Medical Oncology, The Netherlands Cancer Institute , Amsterdam, 1066 CX,; 2. Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute , Amsterdam, 1066 CX,; 3. Department of Pharmacology, Princess Máxima Center for Pediatric Oncology , Utrecht, 3584 CS,; 4. Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University , Utrecht, 3584 CX,; 5. Department of Medical Oncology, University Medical Center Utrecht, Utrecht University , Utrecht, 3584 CX,

Source PDF DOI Publisher page

Expert Matching · Case Demo

Turn Your Submission Goalsinto a Verifiable Journal Plan

Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.

CrushSCI online

Client

I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?

CrushSCI

Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.

Suggested title
Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment

SampleLatest 5 valid paper samples from 2026

Average review96.4 days

Median77 days

Contact CrushSCI

Contact CrushSCI

Leave your contact details so we can discuss your manuscript, editing needs, and submission plan.

Selected service: Paper Editing Service

Or leave your contact details

WhatsApp, Telegram, WeChat, and email are all optional, but at least one is required. Once received, we will contact you as soon as possible.